According to a report from the Associated Press, generic bicalutamide (the generic form of Casodex) is now available in the USA after approval by the US Food and Drug Administration. This offers a significant potential cost saving for many prostate cancer patients that they may want to take advantage of.
Filed under: Living with Prostate Cancer, Management, Treatment Tagged: | bicalutamide, Casodex, generic
Search for new and
ongoing trials on the
CTAG PCa web site
